局部止痛藥市場規模、佔有率和成長分析（按治療層級、劑型、性別、年齡層、類型、配銷通路和地區）- 2025-2032 年行業預測

2023 年全球局部止痛藥市場規模價值 112 億美元，預計將從 2024 年的 120.2 億美元成長到 2032 年的 211.2 億美元，預測期內（2025-2032 年）的複合年成長率為 7.3%。

關節炎盛行率上升、老年人口增加以及運動員使用率增加是推動局部止痛藥市場成長的主要因素。根據全面的全球市場報告，由於關節炎、骨骼疾病、糖尿病神經病變、癌症相關不適等病例的增加，該行業正呈現強勁發展勢頭。局部止痛產品受到青睞，因為它們比口服藥物副作用少。然而，潛在的皮膚刺激和難聞的氣味等挑戰可能會阻礙市場的發展。然而，線上分銷管道和尚未開發的新興市場的成長為市場擴張提供了良好的機會。這種不斷變化的情況凸顯了局部止痛領域面臨的挑戰和潛在的成長途徑。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 客戶和購買標準分析
• 監管分析

局部止痛藥市場規模（按治療層級和複合年成長率） (2025-2032)

• 市場概況
• 非鴉片類藥物
  • 非類固醇消炎劑(NSAID)
  • 甲基水楊酸
  • 辣椒素
  • Lidocaine
  • 其他非鴉片類藥物
• 鴉片類藥物
  • Buprenornhine
  • Fentanyl

局部止痛藥市場規模（按劑型和複合年成長率） (2025-2032)

• 市場概況
• 奶油
• 凝膠
• 噴
• 修補
• 其他

局部止痛藥市場規模：性別與複合年成長率（2025-2032）

• 市場概況
• 女士
• 男性

局部止痛藥市場規模（依年齡層分類）及複合年成長率（2025-2032 年）

• 市場概況
• 成人（18-64歲）
• 老年人（65歲以上）

局部止痛藥市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• 處方止痛藥
• 非處方止痛藥

局部止痛藥市場規模（按分銷管道和複合年成長率） (2025-2032)

• 市場概況
• 藥局和藥局
• 零售商
• 網路商店

局部止痛藥市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Johnson & Johnson（United States）
• GlaxoSmithKline plc（United Kingdom）
• Novartis AG（Switzerland）
• Pfizer Inc.（United States）
• Reckitt Benckiser Group plc（United Kingdom）
• Sun Pharmaceutical Industries Ltd.（India）
• Endo International plc（Ireland）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Sanofi SA（France）
• Mylan NV（now part of Viatris Inc.）（United States）
• AdvaCare Pharma（United States）
• Topical Biomedics Inc.（United States）

結論和建議

Global Topical Pain Relief Market size was valued at USD 11.2 billion in 2023 and is poised to grow from USD 12.02 billion in 2024 to USD 21.12 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The rising prevalence of arthritis is a key factor driving the growth of the topical pain relief market, alongside an expanding elderly population and increased use among athletes. According to a comprehensive global market report, the industry experiences significant momentum due to rising cases of arthritis, bone disorders, diabetic neuropathy, and cancer-associated discomfort. Topical pain relief products are favored for their reduced side effects compared to oral medications. However, challenges such as potential skin irritation and unpleasant odors could hinder market progress. Nevertheless, the growth of online distribution channels and untapped markets in developing regions present promising opportunities for expansion. This evolving landscape highlights both the challenges and potential avenues for growth in the topical pain relief sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segments Analysis

Global Topical Pain Relief Market is segmented by Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel and region. Based on Therapeutic Classes, the market is segmented into Non-opioids and Opioids. Based on Formulation, the market is segmented into Cream, Gel, Spray, Patch and Others. Based on Gender, the market is segmented into Women and Men. Based on Age Group, the market is segmented into Adults (18-64 Years) and Geriatric (65 Years and Above). Based on Type, the market is segmented into Prescription Pain Relief and Over the Counter (OTC) Pain Relief. Based on Distribution Channel, the market is segmented into Pharmacy and Drug Stores, Retail Stores and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Pain Relief Market

The increasing prevalence of chronic pain conditions, including arthritis, musculoskeletal disorders, and neuropathic pain, serves as a significant catalyst for the growth of the global topical pain relief market. As more individuals experience these persistent health issues, there is an rising demand for effective, localized pain management options. Consumers are increasingly inclined towards solutions that provide both convenience and targeted relief, which topical treatments can offer. This trend highlights the importance of developing innovative and user-friendly products that cater to the specific needs of patients, driving market expansion and creating opportunities for companies in this sector.

Restraints in the Global Topical Pain Relief Market

Although topical pain relief products are commonly utilized, a significant restraint in the global market lies in the lack of comprehensive clinical evidence supporting their efficacy and safety. This gap in research affects consumer trust and can hinder the widespread adoption of these products. The uncertainty surrounding their performance may lead potential users to seek alternative pain relief options, thereby limiting market growth. Strengthening clinical trials and providing clearer data on the effectiveness and safety profiles of topical pain relief formulations are essential strategies that need to be addressed to enhance consumer confidence and encourage greater market acceptance.

Market Trends of the Global Topical Pain Relief Market

The Global Topical Pain Relief market is experiencing a notable trend towards the use of natural and herbal ingredients in its products, driven by a growing consumer preference for wellness-oriented solutions. As awareness of the potential side effects associated with synthetic components rises, more individuals are seeking topical pain relief options that prioritize natural formulations. This shift is not only indicative of a broader demand for cleaner, greener health products but also reflects an emerging inclination towards holistic approaches to pain management. Consequently, manufacturers are pivoting to incorporate organic, plant-based ingredients, aligning with consumer interests in sustainability and superior health benefits.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Regulatory Analysis

Global Topical Pain Relief Market Size by Therapeutic Classes & CAGR (2025-2032)

• Market Overview
• Non-opioids
  • Nonsteroidal anti-inflammatory drug (NSAIDS)
  • Methyl salicylates
  • Capsaicin
  • Lidocaine
  • Other non-opioids
• Opioids
  • Buprenorphine
  • Fentanyl

Global Topical Pain Relief Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Cream
• Gel
• Spray
• Patch
• Others

Global Topical Pain Relief Market Size by Gender & CAGR (2025-2032)

• Market Overview
• Women
• Men

Global Topical Pain Relief Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adults (18-64 Years)
• Geriatric (65 Years and Above)

Global Topical Pain Relief Market Size by Type & CAGR (2025-2032)

• Market Overview
• Prescription Pain Relief
• Over the Counter (OTC) Pain Relief

Global Topical Pain Relief Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Pharmacy and Drug Stores
• Retail Stores
• Online Stores

Global Topical Pain Relief Market Size & CAGR (2025-2032)

• North America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • US
  • Canada
• Europe (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (now part of Viatris Inc.) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AdvaCare Pharma (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topical Biomedics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations